Akiko Okifuji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akiko Okifuji has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Dennis C. Turk
Department of Anesthesiology and Pain Medicine, University of Washington
5 shared publications- Bradford D. Hare
University of Utah
3 shared publications Bradford D. Hare
University of Utah
2 shared publicationsDavid H. Bradshaw
Pain Research and Management Center, Department of Anesthesiology, University of Utah
2 shared publicationsGary W. Donaldson
Pain Research and Management Center, Department of Anesthesiology, University of Utah
2 shared publications- Gary W. Donaldson
College of Nursing University of Utah Utah Utah USA
2 shared publications
Latest Publications
- Open Access
- 7 August 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (5) , e1311
Physical activity and racial discrimination involvement in pain sensitivity in Asian Americans and non-Hispanic Whites
Introduction: Little is known about racial differences in pain between Asian-American (AsA) and non-Hispanic White (NHW) adults. Physical activity (PA) and racial discrimination may explain racial differences in pain, but more research is warranted with AsA individuals. Objectives: This study examined the racial differences in pain sensitivity and PA between AsA and NHW adults and association of racial discrimination with pain sensitivity in AsA adults. Methods: This case–control study was conducted with 33 AsA and 27 NHW healthy adults at the age between 18 and 35. Laboratory pain sensitivity was assessed via pain ratings during cold pressor test (CPT) that consisted of immersing the right hand into cold-water bath for 2 minutes and completion status of CPT. Daily life pain sensitivity was assessed via the Pain Sensitivity Questionnaire (PSQ), Brief Fear of Negative Evaluation Scale (BFNES), and Social Pain Questionnaire (SPQ). Physical activity was assessed via the Baecke Physical Activity Questionnaire (BPAQ). Lifetime racial discrimination was assessed via the Subtle and Blatant Racism Scale for AsA (SABRS-A2). Results: Asian-American participants exhibited higher cold pain ratings, PSQ scores, and SPQ scores, and more AsA participants did not complete CPT compared to NHW participants. AsA participants exhibited lower BPAQ scores compared to NHW participants, but the PA levels did not explain the racial differences in pain sensitivity. The SABRS-A2 scores were associated with the PSQ scores. Conclusion: Racial differences in pain sensitivity exist between AsA and NHW adults but are not explained by PA. Racial discrimination may contribute to the racial differences.
- 7 August 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (5) , e1311
Open AccessPhysical activity and racial discrimination involvement in pain sensitivity in Asian Americans and non-Hispanic Whites
Introduction: Little is known about racial differences in pain between Asian-American (AsA) and non-Hispanic White (NHW) adults. Physical activity (PA) and racial discrimination may explain racial differences in pain, but more research is warranted with AsA individuals. Objectives: This study examined the racial differences in pain sensitivity and PA between AsA and NHW adults and association of racial discrimination with pain sensitivity in AsA adults. Methods: This case–control study was conducted with 33 AsA and 27 NHW healthy adults at the age between 18 and 35. Laboratory pain sensitivity was assessed via pain ratings during cold pressor test (CPT) that consisted of immersing the right hand into cold-water bath for 2 minutes and completion status of CPT. Daily life pain sensitivity was assessed via the Pain Sensitivity Questionnaire (PSQ), Brief Fear of Negative Evaluation Scale (BFNES), and Social Pain Questionnaire (SPQ). Physical activity was assessed via the Baecke Physical Activity Questionnaire (BPAQ). Lifetime racial discrimination was assessed via the Subtle and Blatant Racism Scale for AsA (SABRS-A2). Results: Asian-American participants exhibited higher cold pain ratings, PSQ scores, and SPQ scores, and more AsA participants did not complete CPT compared to NHW participants. AsA participants exhibited lower BPAQ scores compared to NHW participants, but the PA levels did not explain the racial differences in pain sensitivity. The SABRS-A2 scores were associated with the PSQ scores. Conclusion: Racial differences in pain sensitivity exist between AsA and NHW adults but are not explained by PA. Racial discrimination may contribute to the racial differences.
- 25 April 2025
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (10) , 2310-2321
A multivariate statistical index, the fibromyalgia analog model, identifies Dahl S rats as a model of fibromyalgia with improved face validity
Fibromyalgia syndrome (FMS) is clinically diagnosed using a widespread pain index and symptom severity scores. Despite this, multivariate statistical models using clinical data consistently suggest the presence of single overarching factor that can capture much of the variation across a spectrum of biomarkers for FMS, potentially aiding diagnosis. We hypothesized that a comparable single index could be developed for preclinical FMS rat models to quantitatively compare and rigorously test new candidates for improved translational potential and therapeutic screening. We used male and female reserpine-treated Sprague Dawley (SD) rats to produce the fibromyalgia analog model (FAM) index, a tool to systematically determine the robustness of potential models of FMS. Features associated with FMS were assessed by behavior tests, including widespread nociceptive sensitivity evaluated on the hind paws (“paw”) and gastrocnemius muscles (“mus”) using a Randall–Selitto device, and face (“VF”) using von Frey filaments; depression (by the forced swim test [FST]); anxiety (using the Elevated Zero Maze [EZM]); and fatigue (using a Home Cage Monitoring system [HCM]). A multivariate statistical analysis was used to determine the FAM index and document internal and external model validity. The index equation was calculated to be F = 0.410 × rz paw + 0.618 × rz mus + 0.429 × rz VF + 0.455 × z FST + 0.183 × RZEZM + 0.160 × rz HCM, where each z is a standardized score. Our data showed the ability of the FAM index to differentiate saline-treated SD rats as a control, “normal” group, vs either acidic saline–injected SD or Dahl S rats as models displaying fibromyalgia-like behaviors.
- 25 April 2025
- Published by Wolters Kluwer Health in Pain
- Vol. 166 (10) , 2310-2321
A multivariate statistical index, the fibromyalgia analog model, identifies Dahl S rats as a model of fibromyalgia with improved face validity
Fibromyalgia syndrome (FMS) is clinically diagnosed using a widespread pain index and symptom severity scores. Despite this, multivariate statistical models using clinical data consistently suggest the presence of single overarching factor that can capture much of the variation across a spectrum of biomarkers for FMS, potentially aiding diagnosis. We hypothesized that a comparable single index could be developed for preclinical FMS rat models to quantitatively compare and rigorously test new candidates for improved translational potential and therapeutic screening. We used male and female reserpine-treated Sprague Dawley (SD) rats to produce the fibromyalgia analog model (FAM) index, a tool to systematically determine the robustness of potential models of FMS. Features associated with FMS were assessed by behavior tests, including widespread nociceptive sensitivity evaluated on the hind paws (“paw”) and gastrocnemius muscles (“mus”) using a Randall–Selitto device, and face (“VF”) using von Frey filaments; depression (by the forced swim test [FST]); anxiety (using the Elevated Zero Maze [EZM]); and fatigue (using a Home Cage Monitoring system [HCM]). A multivariate statistical analysis was used to determine the FAM index and document internal and external model validity. The index equation was calculated to be F = 0.410 × rz paw + 0.618 × rz mus + 0.429 × rz VF + 0.455 × z FST + 0.183 × RZEZM + 0.160 × rz HCM, where each z is a standardized score. Our data showed the ability of the FAM index to differentiate saline-treated SD rats as a control, “normal” group, vs either acidic saline–injected SD or Dahl S rats as models displaying fibromyalgia-like behaviors.
- Top Cited PapersOpen Access
- 30 July 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (12) , 2829-2839
Noninvasive targeted modulation of pain circuits with focused ultrasonic waves
Direct interventions into deep brain circuits constitute promising treatment modalities for chronic pain. Cingulotomy and deep brain stimulation targeting the anterior cingulate cortex have shown notable improvements in the unpleasantness of pain, but these interventions require brain surgeries. In this study, we have developed an approach that can modulate this deep brain affective hub entirely noninvasively, using low-intensity transcranial-focused ultrasound. Twenty patients with chronic pain received two 40-minute active or sham stimulation protocols and were monitored for one week in a randomized crossover trial. Sixty percent of subjects experienced a clinically meaningful reduction of pain on day 1 and on day 7 following the active stimulation, while sham stimulation provided such benefits only to 15% and 20% of subjects, respectively. On average, active stimulation reduced pain by 60.0% immediately following the intervention and by 43.0% and 33.0% on days 1 and 7 following the intervention. The corresponding sham levels were 14.4%, 12.3%, and 6.6%. The stimulation was well tolerated, and no adverse events were detected. Side effects were generally mild and resolved within 24 hours. Together, the direct, ultrasonic stimulation of the anterior cingulate cortex offers rapid, clinically meaningful, and durable improvements in pain severity.
- 30 July 2024
- Published by Wolters Kluwer Health in Pain
- Vol. 165 (12) , 2829-2839
Top Cited PapersOpen AccessNoninvasive targeted modulation of pain circuits with focused ultrasonic waves
Direct interventions into deep brain circuits constitute promising treatment modalities for chronic pain. Cingulotomy and deep brain stimulation targeting the anterior cingulate cortex have shown notable improvements in the unpleasantness of pain, but these interventions require brain surgeries. In this study, we have developed an approach that can modulate this deep brain affective hub entirely noninvasively, using low-intensity transcranial-focused ultrasound. Twenty patients with chronic pain received two 40-minute active or sham stimulation protocols and were monitored for one week in a randomized crossover trial. Sixty percent of subjects experienced a clinically meaningful reduction of pain on day 1 and on day 7 following the active stimulation, while sham stimulation provided such benefits only to 15% and 20% of subjects, respectively. On average, active stimulation reduced pain by 60.0% immediately following the intervention and by 43.0% and 33.0% on days 1 and 7 following the intervention. The corresponding sham levels were 14.4%, 12.3%, and 6.6%. The stimulation was well tolerated, and no adverse events were detected. Side effects were generally mild and resolved within 24 hours. Together, the direct, ultrasonic stimulation of the anterior cingulate cortex offers rapid, clinically meaningful, and durable improvements in pain severity.
- 7 February 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (8) , 104494
Increased Pain Variability in Patients With Chronic Pain: A Role for Pain Catastrophizing
- 7 February 2024
- Published by Elsevier in The Journal of Pain
- Vol. 25 (8) , 104494
Increased Pain Variability in Patients With Chronic Pain: A Role for Pain Catastrophizing
- Open Access
- 13 July 2023
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 4, 1236538
Editorial: Insights in cancer pain: 2022
Editorial: Insights in cancer pain: 2022
- 13 July 2023
- Published by Frontiers Media SA in Frontiers in Pain Research
- Vol. 4, 1236538
Open AccessEditorial: Insights in cancer pain: 2022
Editorial: Insights in cancer pain: 2022
- Open Access
- 2 May 2023
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 170, 111348
Moment-to-moment relationships between pain, fatigue, and distress as a function of GI symptoms in fibromyalgia
- 2 May 2023
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 170, 111348
Open AccessMoment-to-moment relationships between pain, fatigue, and distress as a function of GI symptoms in fibromyalgia
- 11 April 2022
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 116, 106759
Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial
- 11 April 2022
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 116, 106759
Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial
- 11 April 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (8) , 1448-1459
Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study
- 11 April 2022
- Published by Elsevier in The Journal of Pain
- Vol. 23 (8) , 1448-1459
Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study
- 15 February 2021
- Published by Taylor & Francis in Pain Management
- Vol. 11 (4) , 357-368
The Visual Time Analog Scale: Simple, Novel Measurement Approach to Assess Pain in Patients with Chronic Pain
Aim: We conducted a preliminary evaluation of a newly developed, time-based visual time analog (VITA) scale for measuring pain in chronic pain patients. Materials & methods: 40 patients with chroni...
- 15 February 2021
- Published by Taylor & Francis in Pain Management
- Vol. 11 (4) , 357-368
The Visual Time Analog Scale: Simple, Novel Measurement Approach to Assess Pain in Patients with Chronic Pain
Aim: We conducted a preliminary evaluation of a newly developed, time-based visual time analog (VITA) scale for measuring pain in chronic pain patients. Materials & methods: 40 patients with chroni...
- 16 June 2016
- Published by Taylor & Francis in Pain Management
- Vol. 6 (4) , 383-400
Management of Fibromyalgia Syndrome in 2016
Fibromyalgia syndrome is a chronic pain disorder and defies definitively efficacious therapy. In this review, we summarize the results from the early treatment research as well as recent research evaluating the pharmacological, interventional and nonpharmacological therapies. We further discuss future directions of fibromyalgia syndrome management; we specifically focus on the issues that are associated with currently available treatments, such as the need for personalized approach, new technologically oriented and interventional treatments, the importance of understanding and harnessing placebo effects and enhancement of patient engagement in therapy.
- 16 June 2016
- Published by Taylor & Francis in Pain Management
- Vol. 6 (4) , 383-400
Management of Fibromyalgia Syndrome in 2016
Fibromyalgia syndrome is a chronic pain disorder and defies definitively efficacious therapy. In this review, we summarize the results from the early treatment research as well as recent research evaluating the pharmacological, interventional and nonpharmacological therapies. We further discuss future directions of fibromyalgia syndrome management; we specifically focus on the issues that are associated with currently available treatments, such as the need for personalized approach, new technologically oriented and interventional treatments, the importance of understanding and harnessing placebo effects and enhancement of patient engagement in therapy.